Cargando…

High Prevalence of USA300 Among Clinical Isolates of Methicillin-Resistant Staphylococcus aureus on St. Kitts and Nevis, West Indies

Limited information is available on antimicrobial susceptibility and clonal distribution of Staphylococcus aureus in the Caribbean region. The aims of this study were to determine the prevalence of antimicrobial resistance among S. aureus isolates and to reveal the frequency and population structure...

Descripción completa

Detalles Bibliográficos
Autores principales: Guardabassi, Luca, Moodley, Arshnee, Williams, Andrea, Stegger, Marc, Damborg, Peter, Halliday-Simmonds, Iona, Butaye, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560147/
https://www.ncbi.nlm.nih.gov/pubmed/31231318
http://dx.doi.org/10.3389/fmicb.2019.01123
_version_ 1783425911480123392
author Guardabassi, Luca
Moodley, Arshnee
Williams, Andrea
Stegger, Marc
Damborg, Peter
Halliday-Simmonds, Iona
Butaye, Patrick
author_facet Guardabassi, Luca
Moodley, Arshnee
Williams, Andrea
Stegger, Marc
Damborg, Peter
Halliday-Simmonds, Iona
Butaye, Patrick
author_sort Guardabassi, Luca
collection PubMed
description Limited information is available on antimicrobial susceptibility and clonal distribution of Staphylococcus aureus in the Caribbean region. The aims of this study were to determine the prevalence of antimicrobial resistance among S. aureus isolates and to reveal the frequency and population structure of methicillin-resistant S. aureus (MRSA) in St. Kitts and Nevis, a small island country in the West Indies. A total of 152 S. aureus isolates were collected from consecutive samples submitted to the clinical microbiology laboratory of the main referral hospital from March 2017 to January 2018. Samples came from all units in the hospital and a small number came from external submissions, and comprised a total of 119 clinical specimens and 33 nasal swabs collected from staff and patients. All S. aureus isolates were confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Minimal Inhibitory Concentrations (MICs) of clinically relevant antimicrobials were determined by broth microdilution, and diversity of MRSA isolates was assessed by whole genome sequencing (WGS) analysis. MRSA accounted for 45% (69/152) of the isolates. The highest rates of resistance to non-β-lactam agents were observed for erythromycin (55%), moxifloxacin (41%), and levofloxacin (40%), whereas resistance to the other drugs tested was ≤6%. All isolates were susceptible to ceftaroline, linezolid, teicoplanin, telavancin, and vancomycin. WGS-based multilocus sequence typing (MLST) showed that approximately 88% of the MRSA isolates belonged to ST8. Phylogenetic analysis on 801 single-nucleotide polymorphisms (SNPs) identified among the MRSA ST8 isolates indicates a large degree of genetic diversity. However, all ST8 strains clustered within the distinct clade that defines the USA300 North American Epidemic lineage (Panton-Valentine Leukocidin (PVL) +, arginine catabolic mobile element (ACME) +, Staphylococcal cassettes chromosome mec IVa (SCCmec IVa)). Our data show high levels of methicillin, macrolide, and fluoroquinolone resistance among S. aureus on St. Kitts and Nevis. The USA300 North American epidemic lineage is responsible for the vast majority of MRSA infections on this Caribbean island.
format Online
Article
Text
id pubmed-6560147
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65601472019-06-21 High Prevalence of USA300 Among Clinical Isolates of Methicillin-Resistant Staphylococcus aureus on St. Kitts and Nevis, West Indies Guardabassi, Luca Moodley, Arshnee Williams, Andrea Stegger, Marc Damborg, Peter Halliday-Simmonds, Iona Butaye, Patrick Front Microbiol Microbiology Limited information is available on antimicrobial susceptibility and clonal distribution of Staphylococcus aureus in the Caribbean region. The aims of this study were to determine the prevalence of antimicrobial resistance among S. aureus isolates and to reveal the frequency and population structure of methicillin-resistant S. aureus (MRSA) in St. Kitts and Nevis, a small island country in the West Indies. A total of 152 S. aureus isolates were collected from consecutive samples submitted to the clinical microbiology laboratory of the main referral hospital from March 2017 to January 2018. Samples came from all units in the hospital and a small number came from external submissions, and comprised a total of 119 clinical specimens and 33 nasal swabs collected from staff and patients. All S. aureus isolates were confirmed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Minimal Inhibitory Concentrations (MICs) of clinically relevant antimicrobials were determined by broth microdilution, and diversity of MRSA isolates was assessed by whole genome sequencing (WGS) analysis. MRSA accounted for 45% (69/152) of the isolates. The highest rates of resistance to non-β-lactam agents were observed for erythromycin (55%), moxifloxacin (41%), and levofloxacin (40%), whereas resistance to the other drugs tested was ≤6%. All isolates were susceptible to ceftaroline, linezolid, teicoplanin, telavancin, and vancomycin. WGS-based multilocus sequence typing (MLST) showed that approximately 88% of the MRSA isolates belonged to ST8. Phylogenetic analysis on 801 single-nucleotide polymorphisms (SNPs) identified among the MRSA ST8 isolates indicates a large degree of genetic diversity. However, all ST8 strains clustered within the distinct clade that defines the USA300 North American Epidemic lineage (Panton-Valentine Leukocidin (PVL) +, arginine catabolic mobile element (ACME) +, Staphylococcal cassettes chromosome mec IVa (SCCmec IVa)). Our data show high levels of methicillin, macrolide, and fluoroquinolone resistance among S. aureus on St. Kitts and Nevis. The USA300 North American epidemic lineage is responsible for the vast majority of MRSA infections on this Caribbean island. Frontiers Media S.A. 2019-06-05 /pmc/articles/PMC6560147/ /pubmed/31231318 http://dx.doi.org/10.3389/fmicb.2019.01123 Text en Copyright © 2019 Guardabassi, Moodley, Williams, Stegger, Damborg, Halliday-Simmonds and Butaye. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Guardabassi, Luca
Moodley, Arshnee
Williams, Andrea
Stegger, Marc
Damborg, Peter
Halliday-Simmonds, Iona
Butaye, Patrick
High Prevalence of USA300 Among Clinical Isolates of Methicillin-Resistant Staphylococcus aureus on St. Kitts and Nevis, West Indies
title High Prevalence of USA300 Among Clinical Isolates of Methicillin-Resistant Staphylococcus aureus on St. Kitts and Nevis, West Indies
title_full High Prevalence of USA300 Among Clinical Isolates of Methicillin-Resistant Staphylococcus aureus on St. Kitts and Nevis, West Indies
title_fullStr High Prevalence of USA300 Among Clinical Isolates of Methicillin-Resistant Staphylococcus aureus on St. Kitts and Nevis, West Indies
title_full_unstemmed High Prevalence of USA300 Among Clinical Isolates of Methicillin-Resistant Staphylococcus aureus on St. Kitts and Nevis, West Indies
title_short High Prevalence of USA300 Among Clinical Isolates of Methicillin-Resistant Staphylococcus aureus on St. Kitts and Nevis, West Indies
title_sort high prevalence of usa300 among clinical isolates of methicillin-resistant staphylococcus aureus on st. kitts and nevis, west indies
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560147/
https://www.ncbi.nlm.nih.gov/pubmed/31231318
http://dx.doi.org/10.3389/fmicb.2019.01123
work_keys_str_mv AT guardabassiluca highprevalenceofusa300amongclinicalisolatesofmethicillinresistantstaphylococcusaureusonstkittsandneviswestindies
AT moodleyarshnee highprevalenceofusa300amongclinicalisolatesofmethicillinresistantstaphylococcusaureusonstkittsandneviswestindies
AT williamsandrea highprevalenceofusa300amongclinicalisolatesofmethicillinresistantstaphylococcusaureusonstkittsandneviswestindies
AT steggermarc highprevalenceofusa300amongclinicalisolatesofmethicillinresistantstaphylococcusaureusonstkittsandneviswestindies
AT damborgpeter highprevalenceofusa300amongclinicalisolatesofmethicillinresistantstaphylococcusaureusonstkittsandneviswestindies
AT hallidaysimmondsiona highprevalenceofusa300amongclinicalisolatesofmethicillinresistantstaphylococcusaureusonstkittsandneviswestindies
AT butayepatrick highprevalenceofusa300amongclinicalisolatesofmethicillinresistantstaphylococcusaureusonstkittsandneviswestindies